Literature DB >> 22015481

Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.

Wen-Jin Fu1, Bao-Liang Li, Shao-Bo Wang, Mei-Lian Chen, Ren-Tang Deng, Chang-Qin Ye, Liang Liu, Ai-Juan Fang, Shi-Long Xiong, Shu Wen, Hui-Hua Tang, Zai-Xing Chen, Zhi-Hong Huang, Lan-Fen Peng, Lei Zheng, Qian Wang.   

Abstract

AIM: To assess whether glomerular hyperfiltration (GHF) could result in renal tubular damage in type 2 diabetes mellitus (T2DM) patients.
METHODS: Reference value of estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals based on serum CysC levels. GHF was defined as an eGFR exceeding the sex-specific 97.5th percentile in non-diabetic individuals. In the present study, 30 with GHF, 58 with norm-GFR T2DM, and 24 healthy controls were recruited. Tubular markers, such as urinary N-acetyl-β-D-glucosaminidase (NAG) and kidney injury molecule 1 (KIM-1), as well as serum and urinary neutrophil gelatinase-associated lipocalin (NGAL), were measured and compared. The correlation of these markers with eGFR was analyzed in the GHF group.
RESULTS: The GHF group had higher urinary NGAL and KIM-1 levels but lower serum NGAL level than the norm-GFR and control groups. Slightly decreased serum NGAL and increased urinary NGAL levels were also noted in the norm-GFR group compared with those of the controls. There was no statistical difference in the urinary NAG values among the three groups. Correlation analysis showed that eGFR was positively related to fasting blood glucose (FBG), HbA1c, urinary NGAL, and KIM-1, but negatively with serum NGAL in the GHF group.
CONCLUSION: Higher urinary tubular damage markers were found in T2DM patients with GHF than the norm-GFR and control groups, probably a direct proof that GHF is a deleterious factor for diabetic nephropathy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015481     DOI: 10.1016/j.diabres.2011.09.031

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  28 in total

1.  Novel urinary biomarkers in pre-diabetic nephropathy.

Authors:  Vikas Garg; Manish Kumar; Himansu Sekhar Mahapatra; Anubhuti Chitkara; Adesh Kumar Gadpayle; Venketansan Sekhar
Journal:  Clin Exp Nephrol       Date:  2015-01-30       Impact factor: 2.801

2.  Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Robert G Nelson; Robert L Hanson; Joseph V Bonventre; Venkata Sabbisetti; Sushrut S Waikar; Theodore E Mifflin; Xiaoming Zhang; Dawei Xie; Chi-Yuan Hsu; Harold I Feldman; Josef Coresh; Ramachandran S Vasan; Paul L Kimmel; Kathleen D Liu
Journal:  Diabetologia       Date:  2014-10-15       Impact factor: 10.122

Review 3.  Biomarkers in diabetic nephropathy: Present and future.

Authors:  Gemma Currie; Gerard McKay; Christian Delles
Journal:  World J Diabetes       Date:  2014-12-15

Review 4.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

Review 5.  The Promise of Systems Biology for Diabetic Kidney Disease.

Authors:  Frank C Brosius; Wenjun Ju
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

Review 6.  The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.

Authors:  Tomás P Griffin; William Patrick Martin; Nahidul Islam; Timothy O'Brien; Matthew D Griffin
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

Review 7.  Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.

Authors:  Gianfranco Tramonti; Yashpal S Kanwar
Journal:  Endocrine       Date:  2012-10-20       Impact factor: 3.633

8.  Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus.

Authors:  Wen-Jin Fu; Yao-Gao Fang; Ren-Tang Deng; Shu Wen; Mei-Lian Chen; Zhi-Hong Huang; Hui-Hua Tang; Shi-Long Xiong; Xian-Zhang Huang; Qian Wang
Journal:  Endocrine       Date:  2012-07-14       Impact factor: 3.633

9.  Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat.

Authors:  Mei Han; Ying Li; Maodong Liu; Yingmin Li; Bin Cong
Journal:  BMC Nephrol       Date:  2012-06-27       Impact factor: 2.388

10.  Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease.

Authors:  Kwang-Sook Woo; Jae-Lim Choi; Bo-Ram Kim; Ji-Eun Kim; Won-Suk An; Jin-Yeong Han
Journal:  Diabetes Metab J       Date:  2012-08-20       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.